J-P. Janssens (Geneva, Switzerland), A. Bossink (Den Dolder, Netherlands)
Serial testing for tuberculosis infection in a cohort of Indian nursing students: QFT conversions and reversions
P. James, D. J. Christopher, B. Premkumar, L. Armstrong, A. Zwerling, M. Pai (Vellore, India; Montreal, Canada)
|   |
Repeat testing of ELISpot-positive TB contacts at 32 to 36 months post-exposure
C. Chee, K. W. KhinMar, S. H. Gan, T. Barkham, Y. T. Wang (Singapore, Singapore)
| |
Serial testing with the interferon-γ release assay in German healthcare workers
A. Schablon, R. Diel, F. Ringshausen, A. Nienhaus (Hamburg, Germany; , Switzerland)
| |
Serial testing with the interferon-γ release assay in Portuguese healthcare workers
J. Torres Costa, R. Silva, R. Sá, M. J. Cardoso, A. Nienhaus (Porto, Portugal; Hamburg, Germany)
| |
Frequent detection of discordant results of two interferon-γ release assays in an aged population
F. C. Ringshausen, H. Knoop, A. Nienhaus, J. Bünger, V. Harth, F. Hoffmeyer, R. Merget, G. Schultze-Werninghaus, G. Rohde (Bochum, Hamburg, Germany; , Switzerland; , Netherlands)
| |
Use of quantiferon-TB in tube in the diagnosis of active tuberculosis: A multicenter study
M. Losi, A. Fabio, M. L. Bocchino, M. Peracchi, P. Dal Monte, I. Crespi, C. Del Giovane, M. Meacci, A. Sanduzzi, L. Fallico, G. Lombardi, G. Fortina, M. Apice, A. Matarese, R. Manganelli, A. Pace, G. L. Molinari, A. Camaggi, F. Rumpianesi, L. M. Fabbri, L. Richeldi (Modena, Naples, Padua, Bologna, Novara, Italy)
| |
Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection
M. Ruhwald, E. Belard, S. Semb, A. M. Werlinrud, B. Soborg, B. K. Jensen, M. Hetland, I. Nordgaard-Lassen, P. Ravn (Copenhagen, Copenhagen Amager, Denmark)
| |
The value of tuberculin skin test (TST) and interferon – gamma release assay (IGRA) in the diagnosis of latent tuberculosis infection (LTBI) according to age group
K. Lewandowska, U. Demkow, M. Bychawska, J. Kus (Warsaw, Poland)
| |
Performance of the tuberculin skin test and Interferon-gamma release assays for detection of tuberculosis infection in immunocompromised patients in a TB endemic population
A. Socaci, V. Tudorache, G. Nini (Timisoara, Arad, Romania)
| |
QuantiFERON-TB Gold for detection of latent and active tuberculosis infection in immunocompromised versus immune-competent
N. Hasaneen, A. Fathy, A. Fouad, D. Magdi (Egypt)
| |
Performance and post-treatment conversion of latent tuberculosis test (QUANTIFERON) in immunocompromised patients with neoplasmatic disease
G. Hardavella, A. Charpidou, N. Rovina, M. Salomidou, S. Karabela, I. Gkiozos, N. Poulakis (Athens, Greece)
| |
Results of IGRA tests in a prison from a high-TB burden country
A. Sorete Arbore, V. Cojocariu, C. Petrovici, L. Mocanu (Iasi, Romania)
| |
Patients with culture positive active tuberculosis but negative "QuantiFERON-TB Gold in Tube Test" (QFT) – A critical view on the cut-off in clinical praxis
S. Vesenbeckh, T. Bergmann, H. Mauch, H. Rüssmann, N. Schönfeld, T. Blum, T. Bauer (Berlin, Germany)
| |
Concordance between QFT and TST in a cohort of Indian nursing students
D. J. Christopher, P. James, P. Daley, L. Armstrong, B. Premkumar, J. Sarojini Michael, A. Zwerling, M. Pai (Vellore, India; Montreal, Canada)
| |
TB-specific Interferon-γ concentration after treatment of latent TB-infection
A. Nienhaus, J. Torres Costa, R. Silva, R. Sá, M. J. Cardoso (Porto, Portugal; Hamburg, Germany)
| |
High annual risk of TST conversions in a cohort of Indian nursing students
D. J. Christopher, P. James, P. Daley, L. Armstrong, B. Premkumar, A. Zwerling, M. Pai (Vellore, India; Montreal, Canada)
| |